Literature DB >> 1425727

Characteristics of Pseudomonas aeruginosa strains causing septicemia in a Spanish hospital 1981-1990.

F Vázquez1, M C Mendoza, M H Villar, A Vindel, F J Méndez.   

Abstract

The epidemiological and biochemical characteristics of Pseudomonas aeruginosa strains causing septicemia in a Spanish hospital over a ten-year period (1981-1990) were analyzed. A total of 207 episodes, corresponding to 0.7 episodes per 1,000 inpatients and 3.2% of the total number of episodes of septicemia, were registered. Males were more often affected than females (rate 3.2:1). The respiratory (24.6%) and urinary (21.2%) tracts were the main portals of entry, while haematologic and solid tumours (15.4%) were the most frequent underlying diseases. More than 86% of the strains were susceptible to ceftazidime, mezlocillin, piperacillin and amikacin. Seventy strains were subjected to typing and analysis of virulence factors. Serotypes O:6, O:11 and O:2 could be considered endemic (each present in more than 11.4% of strains). Pyocin typing, antibiotyping and resistotyping were preferred as secondary typing methods to phage typing and plasmid profile analysis. The combination of methods revealed a large diversity of strains although some clusters predominated. More than 80% of the strains produced several exoenzymes, possessed pyoverdin and showed haemolytic activity, and all except one showed serum resistance. All strains were susceptible to silver and more than 80% to mercury and boron, but all were resistant to iodine.

Entities:  

Mesh:

Year:  1992        PMID: 1425727     DOI: 10.1007/bf01989973

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  28 in total

1.  The specificity of agglutination reactions of Pseudomonas aeruginosa with O antisera.

Authors:  T L Pitt; Y J Erdman
Journal:  J Med Microbiol       Date:  1978-02       Impact factor: 2.472

2.  Detection time for blood culture isolates using a biphasic medium.

Authors:  I G Julander; M Kalin; L Sjöberg
Journal:  Eur J Clin Microbiol       Date:  1983-02       Impact factor: 3.267

3.  Pseudomonas aeruginosa bacteremia: a clinical study of 75 patients.

Authors:  A L Baltch; P E Griffin
Journal:  Am J Med Sci       Date:  1977 Sep-Oct       Impact factor: 2.378

4.  Pseudomonas aeruginosa bacteremia: relationship of bacterial enzyme production and pyocine types with clinical prognosis in 100 patients.

Authors:  A L Baltch; P E Griffin; M Hammer
Journal:  J Lab Clin Med       Date:  1979-04

5.  Association of hydroxamate siderophore (aerobactin) with Escherichia coli isolated from patients with bacteremia.

Authors:  J Z Montgomerie; A Bindereif; J B Neilands; G M Kalmanson; L B Guze
Journal:  Infect Immun       Date:  1984-12       Impact factor: 3.441

6.  Pseudomonas bacteremia. Review of 108 cases.

Authors:  M R Flick; L E Cluff
Journal:  Am J Med       Date:  1976-04       Impact factor: 4.965

7.  Serological typing of Pseudomonas aeruginosa: use of commercial antisera and live antigens.

Authors:  C D Brokopp; R Gomez-Lus; J J Farmer
Journal:  J Clin Microbiol       Date:  1977-06       Impact factor: 5.948

Review 8.  Epidemiology of infections due to Pseudomonas aeruginosa.

Authors:  A J Morrison; R P Wenzel
Journal:  Rev Infect Dis       Date:  1984 Sep-Oct

9.  Prevalence of pyocin types of P. aeruginosa in a university hospital during 1981-1986.

Authors:  D Jurado Chacón; A Cueto Espinar; D Rodriguez-Contreras Pelayo; M J Rodriguez López; R Galvez Vergas; R Rodriguez-Contreras Pelayo
Journal:  Eur J Epidemiol       Date:  1987-12       Impact factor: 8.082

10.  Resistance to drugs and heavy metals, colicin production, and biochemical characteristics of selected bovine and porcine Escherichia coli strains.

Authors:  N M Harnett; C L Gyles
Journal:  Appl Environ Microbiol       Date:  1984-11       Impact factor: 4.792

View more
  5 in total

1.  Bacterial lipopolysaccharide (LPS)-specific antibodies in commercial human immunoglobulin preparations: superior antibody content of an IgM-enriched product.

Authors:  M Trautmann; T K Held; M Susa; M A Karajan; A Wulf; A S Cross; R Marre
Journal:  Clin Exp Immunol       Date:  1998-01       Impact factor: 4.330

2.  Preparation and preclinical evaluation of a novel liposomal complete-core lipopolysaccharide vaccine.

Authors:  E Bennett-Guerrero; T J McIntosh; G R Barclay; D S Snyder; R J Gibbs; M G Mythen; I R Poxton
Journal:  Infect Immun       Date:  2000-11       Impact factor: 3.441

3.  Characteristics of Pseudomonas aeruginosa strains isolated from urinary tract infections.

Authors:  H Puzová; L Siegfried; M Kmetová; J Durovicová; A Kerestesová
Journal:  Folia Microbiol (Praha)       Date:  1994       Impact factor: 2.099

4.  Epidemiological characteristics of Pseudomonas aeruginosa strains causing infection in an Italian general hospital. A one-year surveillance.

Authors:  A Grigis; C Farina; F Moioli; M Parea; D M Cirillo; A Goglio; G Marchiaro
Journal:  Eur J Epidemiol       Date:  1995-06       Impact factor: 8.082

5.  Pseudomonas aeruginosa RRALC3 Enhances the Biomass, Nutrient and Carbon Contents of Pongamia pinnata Seedlings in Degraded Forest Soil.

Authors:  Parthasarathy Radhapriya; Andimuthu Ramachandran; Rangasamy Anandham; Sundararajan Mahalingam
Journal:  PLoS One       Date:  2015-10-13       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.